CTLA4 and neoplasm: In brain metastases treated with immunotherapy, initial observations were made in melanoma patients receiving an anti-CTLA-4 antibody, where some individuals showed early enlargement of tumor lesions, followed by a decrease or stabilization of tumor burden in later evaluations [28].